Regenerative Medicine
PRP, PRF, PRGF, BMAC, exosomes, peptides — what they are, when they work, when they don't, and the primary papers behind each claim.
-
July 27, 2025
Inflammaging, Longevity, and the Unknowns of Exosome Therapy: A Cautionary View
Inflammaging is a driver of age-related disease, not just a symptom. Exosomes may help, but in a largely unregulated market the variability between batches — even from the same source tissue — makes caution non-optional.
-
June 18, 2025
Botox: A Closer Look at Its Use, Risks, and the Importance of Patient Screening
Fifteen years of ~20 units every 4–6 months, then I stopped — hip abduction nearly doubled from 90–100 lbs to 180 lbs and I pulled up unassisted for the first time. The Alzheimer's link is my working hypothesis, not established fact. The strength data is mine.
-
March 10, 2025
When Exosome Therapy Goes Wrong
Three real cases of serious complications from IV exosome therapy — cancer recurrence, DVT, systemic inflammation — plus what I've learned about source verification, batch characterization, and why microneedling is a very different risk profile than IV.
-
February 4, 2025
Microneedling with Exosomes: How It Works and What to Verify
Microneedling with exosomes can produce visibly better skin in a single session — when the exosomes are high-quality. The mechanism, the indications beyond skin, the risks of poorly processed product, and what to ask any provider.
-
February 3, 2025
What Exosomes Actually Are, and What They Aren't
Exosomes are extracellular vesicles — signals, not cells — that may reduce inflammation and accelerate healing. They're also wrapped in marketing claims that don't hold up. What the science supports, what the FDA says, and what to ask any provider.
-
February 1, 2025
Exosome Therapy vs. Stem Cell Therapy: What's the Difference?
Stem cells rebuild tissue; exosomes signal existing cells to do the work. The clinical, regulatory, and risk profiles are different enough that the choice matters. What I've learned from being a patient in both.
-
January 20, 2025
Longevity, Sarcopenia, and the Anti-Aging Toolkit
What I've learned working with Bodor, Paul, Cugat, Cook, Kuo, and Tamayo on the muscle-first view of aging — Emsculpt Neo, Emface, PRP, BMAC, exosomes, and why I stopped Botox and gained 80+ lbs of hip abduction strength.
-
January 20, 2025
Regenerative Medicine in Orthopedics: What the Evidence Supports
Stem cells, PRP, PRGF, and exosomes have a real role in orthopedic care — for the right indication, with the right operator, under the right regulatory framework. Here's where the evidence lands and what to ask before any injection.
-
January 20, 2025
Regenerative Options for Sports Injuries, From PRP to Wharton's Jelly
PRP, PRGF, BMAC, mFAT, donor MSCs, Wharton's jelly, exosomes — the regenerative toolkit for sports injuries is bigger than most athletes know. What each is good for, what each isn't, and where the regulatory lines sit.
-
January 19, 2025
Does PRP Work? Platelet-Rich Plasma and Related Therapies (PRP, PRF, PRGF)
PRP, PRF, and PRGF helped me avoid a second spinal fusion and recover function across hips, knees, and feet. What the therapies actually do, why operator skill is the variable that matters, and what the FDA does and doesn't regulate.
-
January 19, 2025
What Actually Worked for My Chronic Pain
A daily pain level of 9 is now a 1–2. The combination that got me there: PRP and PRGF for structural repair, exosomes for inflammation, osteopathic care for alignment, and a small group of named physicians who actually understood the conditions.